Zymeworks ZYME
NASDAQ ZYME
$29.41 -0.49 (-1.64%)
As of: Sep 4, 2026 · 3:17 PM EDT

Zymeworks (ZYME) Change in Cash (2021 - 2026)

Zymeworks (ZYME) posted Change in Cash of $203.1 million for Q1 2026, up 957.9% sequentially from -$23.7 million in Q4 2025, and up 1910.94% YoY from $10.1 million in Q1 2025.

Analysis

Zymeworks (ZYME) Change in Cash (2021 - 2026) Analysis & Trends

Zymeworks has reported Change in Cash for 6 years, with the latest figure at $203.1 million in Q1 2026.

  • Quarterly Change in Cash rose 1910.94% year-over-year to $203.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $168.1 million (up 535.32% YoY) and the FY2025 annual result came in at -$24.9 million, up 72.72% from the prior year.
  • Change in Cash climbed to $203.1 million in Q1 2026 per ZYME's latest filing, from -$23.7 million in the prior quarter.
  • Over five years, Change in Cash peaked at $304.8 million in Q4 2022 and troughed at -$219.3 million in Q1 2023.
  • A 5-year average of $2.5 million and a median of -$33.4 million in 2025 frame the typical range for Change in Cash.
  • The sharpest annual moves came in 2023 and 2026: Change in Cash plunged 397.8% in 2023, then soared 1910.94% in 2026.
  • Over 5 years, Change in Cash stood at $304.8 million in 2022, then plunged by 79.26% to $63.2 million in 2023, then slumped by 188.97% to -$56.3 million in 2024, then jumped by 57.91% to -$23.7 million in 2025, then soared by 957.9% to $203.1 million in 2026.
  • According to Business Quant data, Change in Cash over the past three periods registered $203.1 million, -$23.7 million, and -$33.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Cash (Qtr)
1 Vertex Pharmaceuticals 138.43 Bn 130.58 Bn 2.84 Bn 649.20 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -504.60 Mn
3 Argenx Se 63.34 Bn 58.15 Bn 1.37 Bn -
4 Moderna 57.98 Bn 52.85 Bn 52.00 Mn -185.00 Mn
5 Revolution Medicines 43.98 Bn 43.98 Bn - 374.50 Mn
6 BeOne Medicines 39.92 Bn 34.82 Bn 1.53 Bn 427.25 Mn
7 Alnylam Pharmaceuticals 35.42 Bn 32.11 Bn 992.69 Mn -2.94 Mn
8 Royalty Pharma 28.42 Bn 27.58 Bn - 225.59 Mn
9 Insmed 27.36 Bn 26.20 Bn 358.27 Mn -37.42 Mn
10 Zymeworks 2.15 Bn 1.88 Bn - -64.87 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -64.87 Mn
Mar 31, 2026 203.13 Mn
Dec 31, 2025 -23.68 Mn
Sep 30, 2025 -33.42 Mn
Jun 30, 2025 22.05 Mn
Mar 31, 2025 10.10 Mn
Dec 31, 2024 -56.25 Mn
Sep 30, 2024 51.39 Mn
Jun 30, 2024 -43.85 Mn
Mar 31, 2024 -42.74 Mn
Dec 31, 2023 63.23 Mn
Sep 30, 2023 -47.77 Mn
Jun 30, 2023 -39.48 Mn
Mar 31, 2023 -219.33 Mn
Dec 31, 2022 304.83 Mn
Sep 30, 2022 -102.57 Mn
Jun 30, 2022 -76.87 Mn
Mar 31, 2022 73.65 Mn
Dec 31, 2021 -51.57 Mn